564 Preclinical rationale for a first-in-human trial to evaluate the safety and preliminary efficacy of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) for mucosal pemphigus vulgaris

作者： A.S. Payne , J. Lee , D.K. Lundgren , X. Mao , S. Manfredo-Vieira

DOI: 10.1016/J.JID.2020.03.574

关键词: